Introduction: Cisplatin (CDDP) often causes acute kidney injury (AKI), and magnesium supplementation has been suggested to be important in preventing CDDP-induced AKI. Sodium bicarbonate Ringer’s solution (BRS) is a crystalloid solution composed of various electrolytes, including Mg2+, and can be generally used to supplement missing extracellular fluid and correct metabolic acidosis; however, the clinical outcomes of hydration with BRS for CDDP-induced AKI remain unclear. In this study, we retrospectively compared the effects of BRS and normal saline for hydration in patients undergoing CDDP treatment. Methods: We analyzed the incidence rate of AKI (grade ≥ 1), the severity of AKI, the serum magnesium level, and the incidence rate of grade ≥ 3 hematological toxicities (leukopenia, neutropenia, anemia, or thrombocytopenia) following CDDP and fluorouracil (5-FU) administration in 131 in-patients who received CDDP and 5-FU for the first time to treat esophageal cancer. Results: Fifty-six patients (43%) received saline alone, while 75 patients (57%) received BRS for hydration. The incidence rate of AKI (grade ≥ 1) was significantly lower in the BRS group (11%) than that in the saline group (39%, p < 0.001). Moreover, severe AKI (grade ≥ 2) was significantly less common in the BRS group than in the saline group. Although the serum magnesium levels before CDDP administration were not significantly different between the two groups (p = 0.939), the serum magnesium levels on days 2–3 after CDDP administration in the BRS group were significantly higher than those in the saline group (p < 0.001). In contrast, there were no significant differences in the incidence rates of hematological toxicity between the two groups. Multivariate analysis revealed that BRS use was an independent factor that significantly contributed to AKI prevention (odds ratio = 0.061, p < 0.001). Conclusion: Hydration with BRS could prevent CDDP-induced AKI in patients with esophageal cancer.

1.
Rozencweig
M
,
von Hoff
DD
,
Slavik
M
,
Muggia
FM
.
Cis-diamminedichloroplatinum (II). A new anticancer drug
.
Ann Intern Med
.
1977
;
86
(
6
):
803
12
.
2.
Pabla
N
,
Dong
Z
.
Cisplatin nephrotoxicity: mechanisms and renoprotective strategies
.
Kidney Int
.
2008
;
73
(
9
):
994
1007
.
3.
Schilsky
RL
,
Barlock
A
,
Ozols
RF
.
Persistent hypomagnesemia following cisplatin chemotherapy for testicular cancer
.
Cancer Treat Rep
.
1982
;
66
(
9
):
1767
9
.
4.
Lajer
H
,
Daugaard
G
.
Cisplatin and hypomagnesemia
.
Cancer Treat Rev
.
1999
;
25
(
1
):
47
58
.
5.
Lajer
H
,
Kristensen
M
,
Hansen
HH
,
Nielsen
S
,
Frøkiaer
J
,
Ostergaard
LF
, et al
.
Magnesium depletion enhances cisplatin-induced nephrotoxicity
.
Cancer Chemother Pharmacol
.
2005
;
56
(
5
):
535
42
.
6.
Willox
JC
,
McAllister
EJ
,
Sangster
G
,
Kaye
SB
.
Effects of magnesium supplementation in testicular cancer patients receiving cis-platin: a randomised trial
.
Br J Cancer
.
1986
;
54
(
1
):
19
23
.
7.
Yoshida
T
,
Niho
S
,
Toda
M
,
Goto
K
,
Yoh
K
,
Umemura
S
, et al
.
Protective effect of magnesium preloading on cisplatin-induced nephrotoxicity: a retrospective study
.
Jpn J Clin Oncol
.
2014
;
44
(
4
):
346
54
.
8.
Greystoke
AP
,
Jodrell
DI
,
Cheung
M
,
Rivans
I
,
Mackean
MJ
.
How many cisplatin administration protocols does your department use
.
Eur J Cancer Care
.
2010
;
19
(
1
):
80
90
.
9.
Ma
J
,
Han
S
,
Liu
X
,
Zhou
Z
.
Sodium bicarbonated Ringer’s solution effectively improves coagulation function and lactic acid metabolism in patients with severe multiple injuries and traumatic shock
.
Am J Transl Res
.
2021
;
13
(
5
):
5043
50
.
10.
Bian
Y
,
Xu
T
,
Le
Y
,
Li
S
.
The efficacy and safety of sodium bicarbonate Ringer’s solution in critically ill patients: a retrospective cohort study
.
Front Pharmacol
.
2022
;
13
:
829394
.
11.
Yao
X
,
Panichpisal
K
,
Kurtzman
N
,
Nugent
K
.
Cisplatin nephrotoxicity: a review
.
Am J Med Sci
.
2007
;
334
(
2
):
115
24
.
12.
Filipski
KK
,
Loos
WJ
,
Verweij
J
,
Sparreboom
A
.
Interaction of cisplatin with the human organic cation transporter 2
.
Clin Cancer Res
.
2008
;
14
(
12
):
3875
80
.
13.
Ciarimboli
G
,
Ludwig
T
,
Lang
D
,
Pavenstädt
H
,
Koepsell
H
,
Piechota
HJ
, et al
.
Cisplatin nephrotoxicity is critically mediated via the human organic cation transporter 2
.
Am J Pathol
.
2005
;
167
(
6
):
1477
84
.
14.
Yokoo
K
,
Murakami
R
,
Matsuzaki
T
,
Yoshitome
K
,
Hamada
A
,
Saito
H
.
Enhanced renal accumulation of cisplatin via renal organic cation transporter deteriorates acute kidney injury in hypomagnesemic rats
.
Clin Exp Nephrol
.
2009
;
13
(
6
):
578
84
.
15.
Yamamoto
Y
,
Watanabe
K
,
Tsukiyama
I
,
Matsushita
H
,
Yabushita
H
,
Matsuura
K
, et al
.
Nephroprotective effects of hydration with magnesium in patients with cervical cancer receiving cisplatin
.
Anticancer Res
.
2015
;
35
(
4
):
2199
204
.
16.
Chirino
YI
,
Pedraza-Chaverri
J
.
Role of oxidative and nitrosative stress in cisplatin-induced nephrotoxicity
.
Exp Toxicol Pathol
.
2009
;
61
(
3
):
223
42
.
17.
Miller
RP
,
Tadagavadi
RK
,
Ramesh
G
,
Reeves
WB
.
Mechanisms of cisplatin nephrotoxicity
.
Toxins
.
2010
;
2
(
11
):
2490
518
.
18.
Sánchez-González
PD
,
López-Hernández
FJ
,
López-Novoa
JM
,
Morales
AI
.
An integrative view of the pathophysiological events leading to cisplatin nephrotoxicity
.
Crit Rev Toxicol
.
2011
;
41
(
10
):
803
21
.
19.
Solanki
MH
,
Chatterjee
PK
,
Gupta
M
,
Xue
X
,
Plagov
A
,
Metz
MH
, et al
.
Magnesium protects against cisplatin-induced acute kidney injury by regulating platinum accumulation
.
Am J Physiol Ren Physiol
.
2014
;
307
(
4
):
F369
84
.
20.
Finfer
S
,
Liu
B
,
Taylor
C
,
Bellomo
R
,
Billot
L
,
Cook
D
, et al
.
Resuscitation fluid use in critically ill adults: an international cross-sectional study in 391 intensive care units
.
Crit Care
.
2010
;
14
(
5
):
R185
.
21.
Yunos
NM
,
Bellomo
R
,
Hegarty
C
,
Story
D
,
Ho
L
,
Bailey
M
.
Association between a chloride-liberal vs chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults
.
JAMA
.
2012
;
308
(
15
):
1566
72
.
22.
Semler
MW
,
Rice
TW
.
Saline is not the first choice for crystalloid resuscitation fluids
.
Crit Care Med
.
2016
;
44
(
8
):
1541
4
.
23.
Semler
MW
,
Self
WH
,
Wanderer
JP
,
Ehrenfeld
JM
,
Wang
L
,
Byrne
DW
, et al
.
Balanced crystalloids versus saline in critically ill adults
.
N Engl J Med
.
2018
;
378
(
9
):
829
39
.
24.
Goda
M
,
Kanda
M
,
Yoshioka
T
,
Yoshida
A
,
Murai
Y
,
Zamami
Y
, et al
.
Effects of 5-HTEffects of 5-HT3 receptor antagonists on cisplatin-induced kidney injury receptor antagonists on cisplatin-induced kidney injury
.
Clin Transl Sci
.
2021
;
14
(
5
):
1906
16
.
25.
Takemura
M
,
Ikemura
K
,
Kondo
M
,
Yamane
F
,
Ueda
M
,
Okuda
M
.
Concomitant palonosetron ameliorates cisplatin-induced nephrotoxicity, nausea, and vomiting: a retrospective cohort study and pharmacovigilance analysis
.
J Pharm Health Care Sci
.
2022
;
8
(
1
):
21
.
26.
Ramesh
G
,
Reeves
WB
.
TNF-alpha mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity
.
J Clin Invest
.
2002
;
110
(
6
):
835
42
.
27.
Ramesh
G
,
Reeves
WB
.
p38 MAP kinase inhibition ameliorates cisplatin nephrotoxicity in mice
.
Am J Physiol Ren Physiol
.
2005
;
289
(
1
):
F166
74
.
28.
Zirak
MR
,
Karimi
G
,
Rahimian
R
,
Jafarian
AH
,
Hayes
AW
,
Mehri
S
.
Tropisetron ameliorates cyclophosphamide-induced hemorrhagic cystitis in rats
.
Eur J Pharmacol
.
2020
;
883
:
173310
.
29.
Gong
S
,
Yan
Z
,
Liu
Z
,
Niu
M
,
Fang
H
,
Li
N
, et al
.
Intestinal microbiota mediates the susceptibility to polymicrobial sepsis-induced liver injury by granisetron generation in mice
.
Hepatology
.
2019
;
69
(
4
):
1751
67
.
30.
Liu
FC
,
Liu
FW
,
Yu
HP
.
Ondansetron attenuates hepatic injury via p38 MAPK-dependent pathway in a rat haemorrhagic shock model
.
Resuscitation
.
2011
;
82
(
3
):
335
40
.
You do not currently have access to this content.